Skip to main content

Advertisement

SpringerLink
Log in

1,25–Dihydroxyvitamin D and 25–hydroxyvitamin D—mediated regulation of TRPV6 (a putative epithelial calcium channel) mRNA expression in Caco–2 cells

  • ORIGINAL CONTRIBUTION
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Summary

Background

TRPV6 is a member of the vanilloid subfamily of transient receptor potential (TRP) proteins and likely functions as an epithelial calcium channel in calcium–transporting organs, such as the intestine, kidney, and placenta. TRPV6 mRNA expression is strongly regulated by 1,25–dihydroxyvitamin D (1,25VD), the active hormonal form of vitamin D, in intestine and in Caco–2 cells, a human colon cancer cell line.

Aim of the study

The aim of the present study was to characterise the mode of regulation of the 1,25VD–mediated TRPV6 mRNA expression and to test the effect of the precursor of 1,25VD namely 25 hydroxyvitamin D (25 VD) on TRPV6 mRNA expression in Caco–2 cells.

Methods

Caco–2 cells were treated in a 2 x 2 format with 1,25VD and the transcriptional inhibitor actinomycin D (AD, 4μg/ml), and also with translational inhibitor cycloheximide (CHX, 10 μg/ml) after 14 days in culture and TRPV6 mRNA levels were determined using reverse transcription–real time PCR.TRPV6 mRNA half life studies were performed by inhibiting transcription followed by sampling at various time points for TRPV6 mRNA. Varying concentrations of 25 VD were used to test their effect on TRPV6 mRNA in the presence of 5% FBS and also in the absence of serum (but containing insulin–transferrin–selenium mixture) for 24 h.

Results

Treatment with 10–7 M 1,25VD for 8 h resulted in a 60–fold increase in TRPV6 mRNA and this increase could be completely blocked with AD. Treatment with CHX to inhibit de novo protein synthesis did not prevent the initiation of 1,25VD–induced TRPV6 expression, although it did reduce the extent of TRPV6 mRNA accumulation. We found that TRPV6 mRNA half–life was 8 h in Caco–2 cells and was not altered by 1,25VD treatment. Finally, we observed that treatment with 10–6 M of the pro–hormone 25 VD for 24 h resulted in a significant increase in TRPV6 expression in Caco–2 cells, which is consistent with the presence of 1α–hydroxylase (CYP27B1) expression in Caco–2 cells and a possible autocrine vitamin D signaling pathway in colon cells.

Conclusions

1,25 dihydroxyvitamin D regulates TRPV6 expression by a process that requires new mRNA and protein synthesis and the point of regulation lies likely at the transcriptional level especially since vitamin D did not increase the half life of TRPV6 mRNA. In addition, the prohormone form of 1,25 dihydroxyvitamin D, i. e. the 25 hydroxyvitamin D, induced TRPV6 mRNA expression in Caco–2 cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Norman AW (1990) Intestinal calcium absorption: a vitamin D–hormone–mediated adaptive response. Am J Clin Nutr 51:290–300

    CAS  Google Scholar 

  2. Bronner F (1991) Calcium transport across epithelia. Int Rev Cytol 131:169–212

    Article  CAS  Google Scholar 

  3. Clapham DE (2003) TRP channels as cellular sensors. Nature 426:517–524

    Article  CAS  Google Scholar 

  4. Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA (1999) Molecular cloning and characterization of a channel–like transporter mediating intestinal calcium absorption. J Biol Chem 274:22739–22746

    Article  CAS  Google Scholar 

  5. Peng JB, Chen XZ, Berger UV, Weremowicz S, Morton CC, Vassilev PM, Brown EM, Hediger MA (2000) Human calcium transport protein CaT1. Biochem Biophys Res Commun 278:326–332

    Article  CAS  Google Scholar 

  6. Wood RJ, Tchack L, Taparia S (2001) 1, 25–Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco–2 human intestinal cell line. BMC Physiol 1:11

    Article  CAS  Google Scholar 

  7. Giuliano AR, Wood RJ (1991) Vitamin D–regulated calcium transport in Caco– 2 cells: unique in vitro model. Am J Physiol 260:G207–G212

    CAS  Google Scholar 

  8. Fleet JC, Wood RJ (1999) Specific 1, 25(OH)2D3–mediated regulation of transcellular calcium transport in Caco–2 cells. Am J Physiol 276:G958–G964

    CAS  Google Scholar 

  9. Song Y, Peng X, Porta A, Takanaga H, Peng JB, Hediger MA, Fleet JC, Christakos S (2003) Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1, 25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 144:3885–3894

    Article  CAS  Google Scholar 

  10. Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R, Carmeliet G (2001) Duodenal calcium absorption in vitamin D receptor–knockout mice: functional and molecular aspects. Proc Natl Acad Sci USA 98:13324–13329

    Article  CAS  Google Scholar 

  11. Jones G, Strugnell SA, DeLuca HF (1998) Current understanding of the molecular actions of vitamin D Physiol Rev 78:1193–1231

    CAS  Google Scholar 

  12. Gonzalez EA, Disthabanchong S, Kowalewski R, Martin KJ (2002) Mechanisms of the regulation of EGF receptor gene expression by calcitriol and parathyroid hormone in UMR 106–01 cells. Kidney Int 61:1627–1634

    Article  CAS  Google Scholar 

  13. Yanaka N, Akatsuka H, Kawai E, Omori K (1998) 1, 25–Dihydroxyvitamin D3 upregulates natriuretic peptide receptor– C expression in mouse osteoblasts. Am J Physiol 275:E965–E973

    CAS  Google Scholar 

  14. Mosavin R, Mellon WS (1996) Posttranscriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1, 25– dihydroxyvitamin D3. Arch Biochem Biophys 332:142–152

    Article  CAS  Google Scholar 

  15. Grumbles RM, Shao L, Jeffrey JJ, Howell DS (1996) Regulation of rat interstitial collagenase gene expression in growth cartilage and chondrocytes by vitamin D3, interleukin–1 beta, and okadaic acid. J Cell Biochem 63:395–409

    Article  CAS  Google Scholar 

  16. Biskobing DM, Fan D, Rubin J (1997) cfms mRNA is regulated posttranscriptionally by 1, 25(OH)2D3 in HL–60 cells. Calcif Tissue Int 61:205–209

    Article  CAS  Google Scholar 

  17. Tobler A, Miller CW, Norman AW, Koeffler HP (1988) 1, 25–Dihydroxyvitamin D3 modulates the expression of a lymphokine (granulocyte–macrophage colony–stimulating factor) posttranscriptionally. J Clin Invest 81:1819–1823

    Article  CAS  Google Scholar 

  18. Mangasarian K, Mellon WS (1993) 1, 25– Dihydroxyvitamin D–3 destabilizes c–myc mRNA in HL–60 leukemic cells. Biochim Biophys Acta 1172:55–63

    CAS  Google Scholar 

  19. Lou YR, Laaksi I, Syvala H, Blauer M, Tammela TL, Ylikomi T, Tuohimaa P (2004) 25–hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells. Faseb J 18:332–334

    CAS  Google Scholar 

  20. Kallay E, Bareis P, Bajna E, Kriwanek S, Bonner E, Toyokuni S, Cross HS (2002) Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol 40:1191–1196

    Article  CAS  Google Scholar 

  21. Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP, Wang L, Burnstein KL, Holick, MF, Koumenis C (2004) Pancreatic cancer cells express 25–Hydroxyvitamin D–1– hydroxylase and their proliferation is inhibited by the prohormone 25–hydroxyvitamin D3. Carcinogenesis 25:1015–1026

    Article  CAS  Google Scholar 

  22. Zehnder D, Evans KN, Kilby MD, Bulmer JN, Innes BA, Stewart PM, Hewison M (2002) The ontogeny of 25–hydroxyvitamin D(3) 1alpha–hydroxylase expression in human placenta and decidua. Am J Pathol 161:105–114

    CAS  Google Scholar 

  23. Segersten U, Correa P, Hewison M, Hellman P, Dralle H, Carling T, Akerstrom G, Westin G (2002) 25–hydroxyvitamin D(3)–1alpha–hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab 87:2967–2972

    Article  CAS  Google Scholar 

  24. Friedrich M, Villena–Heinsen C, Axt– Fliedner R, Meyberg R, Tilgen W, Schmidt W, Reichrath J (2002) Analysis of 25–hydroxyvitamin D3–1alpha–hydroxylase in cervical tissue. Anticancer Res 22:183–186

    CAS  Google Scholar 

  25. Giuliano AR, Franceschi RT, Wood RJ (1991) Characterization of the vitamin D receptor from the Caco–2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys 285:261–269

    Article  CAS  Google Scholar 

  26. Shao A, Wood RJ, Fleet JC (2001) Increased vitamin D receptor level enhances 1, 25–dihydroxyvitamin D3–mediated gene expression and calcium transport in Caco–2 cells. J Bone Miner Res 16:615–624

    Article  CAS  Google Scholar 

  27. Bareis P, Kallay E, Bischof MG, Bises G, Hofer H, Potzi C, Manhardt T, Bland R, Cross HS (2002) Clonal differences in expression of 25–hydroxyvitamin D(3)– 1alpha–hydroxylase, of 25–hydroxyvitamin D(3)–24–hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha, 25–dihydroxyvitamin D(3). Exp Cell Res 276:320–327

    Article  CAS  Google Scholar 

  28. Cross HS, Peterlik M, Reddy GS, Schuster I (1997) Vitamin D metabolism in human colon adenocarcinoma–derived Caco–2 cells: expression of 25–hydroxyvitamin D3–1alpha–hydroxylase activity and regulation of side–chain metabolism. J Steroid Biochem Mol Biol 62:21–28

    Article  CAS  Google Scholar 

  29. Fleet JC, Eksir F, Hance KW, Wood RJ (2002) Vitamin D–inducible calcium transport and gene expression in three Caco–2 cell lines. Am J Physiol Gastrointest Liver Physiol 283:G618–G625

    CAS  Google Scholar 

  30. Peng JB, Brown EM, Hediger MA (2001) Structural conservation of the genes encoding CaT1, CaT2, and related cation channels. Genomics 76:99–109

    Article  CAS  Google Scholar 

  31. Wang TT, Tavera–Mendoza LE, Laperriere D, Libby E, Macleod NB, Nagai Y, Bourdeau V, Konstorum A, Lallement B, Zhang R, Mader S, White JH (2005) Large–scale in silico and microarraybased identification of direct 1, 25–dihydroxyvitamin D3 target genes. Mol Endocrinol (Epub ahead of print)

  32. Heaney RP, Barger–Lux MJ, Dowell MS, Chen TC, Holick MF (1997) Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 82:4111–4116

    Article  CAS  Google Scholar 

  33. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB (2004) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med 351(15):1548–1563

    Article  CAS  Google Scholar 

  34. Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371

    CAS  Google Scholar 

  35. Lamprecht SA, Lipkin M (2004) Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 3:601–614

    Article  CAS  Google Scholar 

  36. Cross HS, Kallay E, Farhan H, Weiland T, Manhardt T (2003) Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention. Recent Results Cancer Res 164:413–425

    CAS  Google Scholar 

  37. Keenan MJ, Holmes RP (1991) The uptake and metabolism of 25–hydroxyvitamin D3 and vitamin D binding protein by cultured porcine kidney cells (LLCPK1). Int J Biochem 23:1225–1230

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. S. Taparia PhD

    Present address: Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston (TX), USA

Authors and Affiliations

  1. Mineral Bioavailability Laboratory, Jean Mayer USDA Human Nutrition, Research Center on Aging, Tufts University, 711 Washington Street, Boston (MA) 02111, USA

    S. Taparia PhD & R. J. Wood PhD

  2. Dept. Foods and Nutrition, Purdue University, West Lafayette (IN), USA

    J. C. Fleet

  3. Dept. of Medicine, Division of Nephrology, University of Alabama at Birmingham, Birmingham (AL), USA

    J.–B. Peng

  4. Nutrition and Cancer Biology Laboratory, Jean Mayer USDA Human Nutrition, Research Center on Aging, Tufts University, Boston (MA), USA

    X. D. Wang

Authors
  1. S. Taparia PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. C. Fleet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J.–B. Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X. D. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. J. Wood PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. J. Wood PhD.

Additional information

* This material is based upon work supported in part by the U. S. Department of Agriculture, under agreement No. 58–1950– 4–401, and the National Institutes of Health grant R01DK64327 (RJW)). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the U. S. Department of Agriculture.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taparia, S., Fleet, J.C., Peng, J. et al. 1,25–Dihydroxyvitamin D and 25–hydroxyvitamin D—mediated regulation of TRPV6 (a putative epithelial calcium channel) mRNA expression in Caco–2 cells. Eur J Nutr 45, 196–204 (2006). https://doi.org/10.1007/s00394-005-0586-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-005-0586-3

Key words

Search

Navigation